Financials (USD)
Sales 2024 * | 25.16M | Sales 2025 * | 81.93M | Capitalization | 293M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | 6M | EV / Sales 2024 * | 14.3 x |
Net Debt 2024 * | 67.4M | Net Debt 2025 * | 48.88M | EV / Sales 2025 * | 4.17 x |
P/E ratio 2024 * |
-7.2
x | P/E ratio 2025 * |
-56.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.99% |
Latest transcript on CorMedix Inc.
Managers | Title | Age | Since |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Mathew David
DFI | Director of Finance/CFO | 47 | 20-05-10 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 16-04-26 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 11-08-14 |
Alan Dunton
BRD | Director/Board Member | 70 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+23.54% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |